By Scott Gottlieb (Original source AEI)
“Senior citizens are facing increasing and often significant burdens from rising out-of-pocket costs on drugs that they need to improve their health while many observers worry about the long run stability of the Part D program. As part of the Prescription Drug Pricing Reduction Act (PDPRA), the Senate Finance Committee is considering two significant reforms to the Medicare Part D program aimed at reducing overall program outlays and beneficiary out-of-pocket spending. Most notably, the proposal would substantially redesign the structure of the Part D benefit to encourage more efficient management of drug spending and reduce incentives that encourage rapid growth of list prices. In addition, it would establish mandatory rebates in Medicare Part D if list prices on drugs grow faster than the rate of inflation (as measured by CPI-U) to reduce enrollee out-of-pocket spending.”
Click here to see more
Newt’s World Episode 777: “Mr. Gorbachev, tear down this wall!”
Newt’s guest is David Trulio, President and CEO of the Ronald Reagan Presidential Foundation and Institute. They discuss the 35th anniversary of the fall of…
Thought Leader: Newt Gingrich
Anderson Cooper 360: Trump Says He Is Not Reconsidering Gaetz As His Pick For AG
Tomorrow the House Ethic Committee is expected to discuss the fate of its report on Matt Gaetz, President-elect Trump’s choice for attorney general. The former Florida…
Thought Leader: Anderson Cooper
Peter Zeihan on the Geopolitics of Gaming
From Peter Zeihan: PC or console? Yes, I’m talking about gaming preferences…and if you answered PC, then we all owe you a big thank you.…
Thought Leader: Peter Zeihan
